Reliability of IUS in Crohn's Disease
Not applicable · Testing Transabdominal intestinal ultrasound · 1 site · Centre Hospitalier Universitaire, Amiens
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Transabdominal intestinal ultrasound. Condition(s) listed: Crohn Disease (CD).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Crohn's disease evolving for at least 1 months
- Patient older than 18 years
- Patient covered by French national health insurance
Plus 1 more requirement(s). There are also 3 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 30 participants are expected to take part.
- Start date: 2022-01-19.
- Main results expected around 2026-02 (estimate from the record).
- 1 study site listed (1 marked recruiting) in France.
Main thing being measured
- Number of different IUS parameters between two operators (1 year)
In the researchers’ words
Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Crohn Disease (CD) |
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
| Enrollment | 30 (estimated) |
| Start date | 2022-01-19 |
| Primary completion (est.) | 2026-02 |
| First posted | 2025-02-18 |
| Last updated | 2025-02-18 |
| Official title | Reliability of IUS in Crohn's Disease |
| ClinicalTrials.gov ID | NCT06833450 |
Interventions
- Transabdominal intestinal ultrasound (Other)
Transabdominal intestinal ultrasound
Full eligibility criteria (from the record)
Inclusion Criteria: * Crohn's disease evolving for at least 1 months * Patient older than 18 years * Patient covered by French national health insurance * Written informed consent Exclusion Criteria: * Pregnant women or breastfeeding * Minor * Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| CHU d'Amiens | Amiens | France | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.